Table 25.
Statements |
---|
MAP.EIM.1 What is the appropriate surveillance strategy for extra-intestinal cancers? No surveillance for extra-intestinal cancers is recommended for MUTYH biallelic carriers. |
Statements |
---|
MAP.EIM.1 What is the appropriate surveillance strategy for extra-intestinal cancers? No surveillance for extra-intestinal cancers is recommended for MUTYH biallelic carriers. |